Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy
Authors
Keywords
Metastasis, Cancer immunotherapy, Cancer treatment, Prognosis, Liver, Lesions, Lymph nodes, Renal cell carcinoma
Journal
PLoS One
Volume 14, Issue 2, Pages e0211105
Publisher
Public Library of Science (PLoS)
Online
2019-02-21
DOI
10.1371/journal.pone.0211105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of High Dose Interleukin-2 in the Era of Targeted Therapy
- (2017) Jessie Gills et al. JOURNAL OF UROLOGY
- Sunitinib Possible Sex-Divergent Therapeutic Outcomes
- (2016) Ignacio Segarra et al. CLINICAL DRUG INVESTIGATION
- Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis
- (2016) Tomas Buchler et al. EUROPEAN UROLOGY
- Sorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic review
- (2016) Guiliang Wang et al. Hepatology International
- Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy
- (2016) Sung Han Kim et al. Cancer Research and Treatment
- Kidney Cancer, Version 3.2015
- (2015) Robert J. Motzer et al. Journal of the National Comprehensive Cancer Network
- The Molecular Biology of Renal Cancer: Another Piece of the Puzzle
- (2014) Grant D. Stewart et al. EUROPEAN UROLOGY
- Renal cell carcinoma
- (2014) E. Jonasch et al. BMJ-British Medical Journal
- Validation of the MSKCC and Heng Risk Criteria Models for Predicting Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib
- (2013) Whi-An Kwon et al. ANNALS OF SURGICAL ONCOLOGY
- Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials
- (2013) Roberto Iacovelli et al. CANCER TREATMENT REVIEWS
- Survival Outcome and Treatment Response of Patients with Late Relapse from Renal Cell Carcinoma in the Era of Targeted Therapy
- (2013) Nils Kroeger et al. EUROPEAN UROLOGY
- Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy
- (2013) Rana R. McKay et al. EUROPEAN UROLOGY
- Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression
- (2013) Claudia A. Dumitru et al. SEMINARS IN CANCER BIOLOGY
- Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer
- (2013) Luís León et al. Targeted Oncology
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Insights into the Management of Renal Cell Cancer
- (2012) Nicolas Pécuchet et al. ONCOLOGY
- Defining an Individualized Treatment Strategy for Metastatic Renal Cancer
- (2012) Brian Hu et al. UROLOGIC CLINICS OF NORTH AMERICA
- Liver Directed Therapy for Renal Cell Carcinoma
- (2012) Russell C. Langan et al. Journal of Cancer
- Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
- (2011) M. Bianchi et al. ANNALS OF ONCOLOGY
- New Perspectives on the Treatment of Metastatic Renal Cell Carcinoma: An Introduction and Historical Overview
- (2011) R. J. Motzer ONCOLOGIST
- Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
- (2008) A A M van der Veldt et al. BRITISH JOURNAL OF CANCER
- Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma
- (2008) Robert J. Motzer et al. CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Racial/Ethnic and Gender Disparities in Renal Cell Carcinoma Incidence and Survival
- (2008) Helen Shi Stafford et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started